tolbutamide has been researched along with dihydroxyphenylalanine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirata, Y; Nagatsu, T | 1 |
| Feldman, JM; Lebovitz, HE | 1 |
| Ambani, LM; Mueller, PS; Rathey, U; Van Woert, MH | 1 |
| Håkanson, R; Lundquist, I; Rerup, C | 1 |
4 other study(ies) available for tolbutamide and dihydroxyphenylalanine
| Article | Year |
|---|---|
Evidence for the involvement of Ca2+-calmodulin and cyclic AMP in the regulation of the tyrosine hydroxylase system in rat striatal tissue slices.
Topics: Animals; Bucladesine; Calcium; Calmodulin; Corpus Striatum; Cyclic AMP; Dihydroxyphenylalanine; In Vitro Techniques; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulfonamides; Tolbutamide; Tyrosine 3-Monooxygenase | 1985 |
Serotonin inhibition of in vitro insulin release from golden hamster pancreas.
Topics: 5-Hydroxytryptophan; Adenine Nucleotides; Animals; Cricetinae; Cyclic AMP; Depression, Chemical; Dihydroxyphenylalanine; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Male; Pancreas; Serotonin; Tolbutamide | 1970 |
Abnormal insulin secretion in Parkinson's disease before and during L-dihydroxyphenylalanine (L-dopa) therapy.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Parkinson Disease; Tolbutamide | 1973 |
On the hyperglycaemic effect of DOPA and dopamine.
Topics: Alloxan; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; Dopamine; Hyperglycemia; Injections, Intravenous; Mice; Monoamine Oxidase Inhibitors; Tolbutamide | 1967 |